|
|
||||||||
Short Communication |



1 Unité d'Epidémiologie et Physiopathologie des Virus Oncogènes, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris cedex 15, France
2 Unité de Rétrovirologie Moléculaire, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris cedex 15, France
3 G5 Virus et Immunité, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris cedex 15, France
Correspondence
Jean-Pierre Vartanian
jpvart{at}pasteur.fr
In the absence of the human immunodeficiency virus type 1 (HIV-1) Vif protein, the host-cell cytidine deaminases APOBEC3F and -3G are co-packaged along with virion RNA. Upon infection of target cells, nascent single-stranded DNA can be edited extensively, invariably giving rise to defective genomes called G
A hypermutants. Although human T-cell leukemia virus type 1 (HTLV-1) replicates in the same cell type as HIV-1, it was shown here that HTLV-1 is relatively resistant to the antiviral effects mediated by human APOBEC3B, -3C, -3F and -3G. Nonetheless, a small percentage of genomes (0·1<f<5 %) were edited extensively: up to 97 % of cytidine targets were deaminated. In contrast, hypermutated HTLV-1 genomes were not identified in peripheral blood mononuclear cell DNA from ten patients with non-malignant HTLV-1 infection. Thus, although HTLV-1 DNA can indeed be edited by at least four APOBEC3 cytidine deaminases in vitro, they are conspicuously absent in vivo.
Supplementary figures are available in JGV Online.
These authors contributed equally to this work.
This article has been cited by other articles:
![]() |
R. Suspene, M. Renard, M. Henry, D. Guetard, D. Puyraimond-Zemmour, A. Billecocq, M. Bouloy, F. Tangy, J.-P. Vartanian, and S. Wain-Hobson Inversing the natural hydrogen bonding rule to selectively amplify GC-rich ADAR-edited RNAs Nucleic Acids Res., July 1, 2008; 36(12): e72 - e72. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Luo, T. Wang, B. Liu, C. Tian, Z. Xiao, J. Kappes, and X.-F. Yu Cytidine Deaminases APOBEC3G and APOBEC3F Interact with Human Immunodeficiency Virus Type 1 Integrase and Inhibit Proviral DNA Formation J. Virol., July 1, 2007; 81(13): 7238 - 7248. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Derse, S. A. Hill, G. Princler, P. Lloyd, and G. Heidecker Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid PNAS, February 20, 2007; 104(8): 2915 - 2920. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Jonsson, G. Hache, M. D. Stenglein, S. C. Fahrenkrug, V. Andresdottir, and R. S. Harris Evolutionarily conserved and non-conserved retrovirus restriction activities of artiodactyl APOBEC3F proteins Nucleic Acids Res., November 14, 2006; 34(19): 5683 - 5694. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Muckenfuss, M. Hamdorf, U. Held, M. Perkovic, J. Lower, K. Cichutek, E. Flory, G. G. Schumann, and C. Munk APOBEC3 Proteins Inhibit Human LINE-1 Retrotransposition J. Biol. Chem., August 4, 2006; 281(31): 22161 - 22172. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |